Table 1 Characteristics of patients with myositis developing cancer
IDGenderDiagnosisDetected antibodiesAge at myositis onset/yearsSite of malignancyTime of cancer onset relative to myositis onset/yearsClassified as CAM
1MDM19LymphomaSame timeYes
2FDM155/14037Breast0.8Yes
3FDMKS, 155/4047Lymphoma2Yes
4MDM48Lymphoma3Yes
5FDM52Ovarian1Yes
6MDMMi-252ColonSame timeYes
7FDM155/14057Breast2Yes
8MDMMi-259Caecum2Yes
9FDM155/14059Breast1Yes
10FDM155/14060UterineSame timeYes
11FDM155/14063OvarianSame timeYes
12FDM155/14063Oesophagus0.3Yes
13MDM63Bladder3Yes
14MDMU1-RNP,155/14069Bladder−0.9Yes
15FDM73BreastSame timeYes
16MMCTDU1-RNP46LungSame timeYes
17FPM35Paget’s nipple4No
18MPMJo-135Lymphoma7No
19FPMJo-148Breast5No
20MPMJo-154Lung12No
21FPM58Breast5No
22MPM68Colon4No
23FSSc overlapJo-118Vulva7No
24MSSc overlapPM-Scl40Colon10No
25FSSc overlap46Lymphoma8No
26FSSc overlapPM-Scl49Pancreas8No
  • PM, polymyositis; DM, dermatomyositis; SSc, systemic sclerosis; MCTD, mixed connective tissue disease; CAM, cancer-associated myositis.